Registered entities
Forma Therapeutics, Inc.
Reg. No. 260428600United States
FORMA THERAPEUTICS HOLDINGS, INC.
Reg. No. 37-1657129United States
Innovation
95 patent families (51 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 37,896 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 21 |
| 2017 | 27 |
| 2018 | 23 |
| 2019 | 36 |
| 2020 | 50 |
| 2021 | 40 |
| 2022 | 33 |
| 2023 | 30 |
| 2024 | 15 |
| 2025 | 14 |
| 2026 | 3 |
Investor mix
15 investors on record; lead investors include Celgene, RA Capital Management, Lilly Ventures, Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 47% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 7 | 47% |